investorscraft@gmail.com

Intrinsic ValueShenzhen Breo Technology Co., Ltd. (688793.SS)

Previous Close$22.36
Intrinsic Value
Upside potential
Previous Close
$22.36

VALUATION INPUT DATA

This valuation is based on fiscal year data as of 2024 and quarterly data as of .

Data is not available at this time.

Stock Valuation Context

Business Model And Market Position

Shenzhen Breo Technology operates as a specialized health technology company focused on the design, research, development, production, and sales of smart portable massagers. The company has established a strong presence in China's consumer electronics sector through its proprietary breo and Beijiao brand products, targeting wellness-conscious consumers with devices for eyes, neck, head, and scalp massage. Breo's market positioning leverages the growing demand for personal health and wellness technology, competing in the premium segment of portable massagers through innovative features and direct-to-consumer sales channels. The company maintains a domestic market focus while developing technologically advanced products that combine massage therapy with smart connectivity, positioning itself as a specialized player in the health-focused consumer electronics niche rather than competing in broader consumer technology markets.

Revenue Profitability And Efficiency

The company generated CNY 1.09 billion in revenue with modest net income of CNY 10.3 million, indicating thin profit margins in the competitive consumer electronics space. Operating cash flow of CNY 83.5 million significantly exceeded net income, suggesting healthy cash conversion from operations. Capital expenditures of CNY -18.5 million indicate the company is maintaining rather than aggressively expanding its production capacity.

Earnings Power And Capital Efficiency

Breo demonstrates limited earnings power with diluted EPS of CNY 0.11, reflecting the challenges of maintaining profitability in a competitive market. The positive operating cash flow relative to net income suggests efficient working capital management. The company's capital allocation appears conservative, focusing on maintaining existing operations rather than pursuing aggressive expansion or market share acquisition.

Balance Sheet And Financial Health

The balance sheet shows solid liquidity with CNY 383.5 million in cash against total debt of CNY 181.3 million, providing a comfortable cash-to-debt ratio. This conservative financial structure supports operational stability and provides buffer against market volatility. The company maintains adequate financial flexibility without excessive leverage, positioning it to weather industry cycles.

Growth Trends And Dividend Policy

The company currently maintains a zero dividend policy, retaining all earnings to fund operations and potential growth initiatives. This approach is typical for growth-oriented technology companies focusing on reinvestment rather than shareholder distributions. The absence of dividends reflects management's priority on preserving capital for research and development and market expansion opportunities within the competitive health technology sector.

Valuation And Market Expectations

With a market capitalization of CNY 2.55 billion, the market values the company at approximately 2.3 times revenue, reflecting moderate growth expectations in the health technology segment. The beta of 1.49 indicates higher volatility than the broader market, typical for specialized technology companies. This valuation suggests cautious optimism about Breo's niche market position and growth potential in the health and wellness sector.

Strategic Advantages And Outlook

Breo's strategic advantage lies in its specialized focus on smart portable massagers and established brand recognition in China's health technology market. The company's domestic market concentration provides deep market understanding but also creates geographic concentration risk. Future success will depend on product innovation, brand strengthening, and potential international expansion while navigating intense competition in the consumer health electronics space.

Sources

Company financial statementsStock exchange disclosuresMarket data providers

show cash flow forecast

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year2025202620272028202920302031203220332034203520362037203820392040204120422043204420452046204720482049

INCOME STATEMENT

Revenue growth rate, %NaN
Revenue, $NaN
Variable operating expenses, $mNaN
Fixed operating expenses, $mNaN
Total operating expenses, $mNaN
Operating income, $mNaN
EBITDA, $mNaN
Interest expense (income), $mNaN
Earnings before tax, $mNaN
Tax expense, $mNaN
Net income, $mNaN

BALANCE SHEET

Cash and short-term investments, $mNaN
Total assets, $mNaN
Adjusted assets (=assets-cash), $mNaN
Average production assets, $mNaN
Working capital, $mNaN
Total debt, $mNaN
Total liabilities, $mNaN
Total equity, $mNaN
Debt-to-equity ratioNaN
Adjusted equity ratioNaN

CASH FLOW

Net income, $mNaN
Depreciation, amort., depletion, $mNaN
Funds from operations, $mNaN
Change in working capital, $mNaN
Cash from operations, $mNaN
Maintenance CAPEX, $mNaN
New CAPEX, $mNaN
Total CAPEX, $mNaN
Free cash flow, $mNaN
Issuance/(repurchase) of shares, $mNaN
Retained Cash Flow, $mNaN
Pot'l extraordinary dividend, $mNaN
Cash available for distribution, $mNaN
Discount rate, %NaN
PV of cash for distribution, $mNaN
Current shareholders' claim on cash, %NaN
HomeMenuAccount